首页 > 最新文献

Klinicka mikrobiologie a infekcni lekarstvi最新文献

英文 中文
[In vitro comparison of antibacterial efficacy of nonadherent antimicrobial dressings]. 非黏附抗菌敷料的体外抗菌效果比较。
Q3 Medicine Pub Date : 2023-06-01
Johana Kučerová, Vojtěch Mezera, Ivo Bureš

Objectives: The use of nonadherent dressings is part of care for chronic wounds. In this paper, we present the results of in vitro activity of several such dressings on bacteria most commonly found in chronic wounds.

Material and methods: Selected bacterial strains were isolated from chronic wounds of patients in Pardubice Hospital in the period from February to May 2022. The following dressings were tested: Inadine and Aqvidine, both containing povidone iodine, Bactigras containing chlorhexidine acetate and Xeroform containing bismuth tribromophenate. The zone of inhibition size and the ability to inhibit growth after dressing removal were evaluated.

Results: Inadine and Aqvidine had significantly larger zones of inhibition than Bactigras or Xeroform. We found no significant differences between Inadine and Aqvidine (except for Klebsiella pneumoniae) or between Bactigras and Xeroform (except for Streptococcus pyogenes). Inadine and Aqvidine were able to inhibit bacterial growth after dressing removal (except for Proteus mirabilis and Pseudomonas aeruginosa). Bactigras and Xeroform did not exhibit this ability, which was only observed for Streptococcus pyogenes after removal of Bactigras.

Conclusions: The dressings Inadine and Aqvidine containing povidone iodine were more effective than Bactigras and Xeroform against all species tested and their antibacterial activity against most strains persisted even after removal. These differences in antibacterial -efficacy should be considered when selecting wound dressings.

目的:使用非粘附敷料是慢性伤口护理的一部分。在本文中,我们提出了几种这种敷料对慢性伤口中最常见的细菌的体外活性的结果。材料与方法:选取2022年2 - 5月帕尔杜比采医院慢性伤口患者中分离的细菌菌株。测试了以下敷料:含有聚维酮碘的Inadine和aquvidine,含有醋酸氯己定的Bactigras和含有三溴苯酸铋的Xeroform。对去除敷料后的抑制区大小和抑制生长的能力进行了评价。结果:吲哚丁和阿维丁的抑制区明显大于巴氏菌素和赛罗酮。我们发现Inadine和Aqvidine(肺炎克雷伯菌除外)或Bactigras和Xeroform(化脓性链球菌除外)之间没有显著差异。除变形杆菌和铜绿假单胞菌外,Inadine和aquvidine均能抑制敷料去除后的细菌生长。Bactigras和Xeroform没有表现出这种能力,这只在去除Bactigras后的化脓性链球菌中观察到。结论:含聚维酮碘的Inadine和Aqvidine敷料对所有菌种的抑菌效果均优于Bactigras和Xeroform,且去除后对大部分菌种的抑菌活性仍保持不变。在选择伤口敷料时应考虑这些抗菌效果的差异。
{"title":"[In vitro comparison of antibacterial efficacy of nonadherent antimicrobial dressings].","authors":"Johana Kučerová, Vojtěch Mezera, Ivo Bureš","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>The use of nonadherent dressings is part of care for chronic wounds. In this paper, we present the results of in vitro activity of several such dressings on bacteria most commonly found in chronic wounds.</p><p><strong>Material and methods: </strong>Selected bacterial strains were isolated from chronic wounds of patients in Pardubice Hospital in the period from February to May 2022. The following dressings were tested: Inadine and Aqvidine, both containing povidone iodine, Bactigras containing chlorhexidine acetate and Xeroform containing bismuth tribromophenate. The zone of inhibition size and the ability to inhibit growth after dressing removal were evaluated.</p><p><strong>Results: </strong>Inadine and Aqvidine had significantly larger zones of inhibition than Bactigras or Xeroform. We found no significant differences between Inadine and Aqvidine (except for Klebsiella pneumoniae) or between Bactigras and Xeroform (except for Streptococcus pyogenes). Inadine and Aqvidine were able to inhibit bacterial growth after dressing removal (except for Proteus mirabilis and Pseudomonas aeruginosa). Bactigras and Xeroform did not exhibit this ability, which was only observed for Streptococcus pyogenes after removal of Bactigras.</p><p><strong>Conclusions: </strong>The dressings Inadine and Aqvidine containing povidone iodine were more effective than Bactigras and Xeroform against all species tested and their antibacterial activity against most strains persisted even after removal. These differences in antibacterial -efficacy should be considered when selecting wound dressings.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"29 2","pages":"36-42"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142979090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Selected aspects of the human microbiome]. [人类微生物组的选定方面]。
Q3 Medicine Pub Date : 2023-06-01
Milan Kolář

This review briefly defines the term microbiome and characterizes its importance in health and disease.

这篇综述简要地定义了微生物组这个术语,并描述了它在健康和疾病中的重要性。
{"title":"[Selected aspects of the human microbiome].","authors":"Milan Kolář","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This review briefly defines the term microbiome and characterizes its importance in health and disease.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"29 2","pages":"46-51"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142978614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Prevalence and genotypes of methicillin-resistant Staphylococcus aureus (MRSA) in humans, animals and foods in the Czech Republic]. [捷克共和国人类、动物和食品中耐甲氧西林金黄色葡萄球菌(MRSA)的流行率和基因型]。
Q3 Medicine Pub Date : 2023-06-01
Renáta Karpíšková, Kristýna Brodíková, Ivana Koláčková

Methicillin-resistant Staphylococcus aureus (MRSA) strains are emerging zoonotic pathogens that are of importance not only to human but also to veterinary medicine. MRSA strains spread among humans and animals and can also be transmitted through foods. In this article, we provide a summary of the prevalence of MRSA in the Czech Republic, focusing on the One Health concept, which explores the relationships between human and animal health and the environment. This approach, together with collaboration between health professionals, veterinarians and public health experts, can provide valuable insights and help in preventing and controlling MRSA outbreaks.

耐甲氧西林金黄色葡萄球菌(MRSA)菌株是新兴的人畜共患病原体,不仅对人类而且对兽医学都很重要。耐甲氧西林金黄色葡萄球菌在人类和动物之间传播,也可以通过食物传播。在这篇文章中,我们总结了MRSA在捷克共和国的流行情况,重点是同一个健康概念,该概念探讨了人类和动物健康与环境之间的关系。这种方法加上卫生专业人员、兽医和公共卫生专家之间的合作,可以提供有价值的见解,并有助于预防和控制耐甲氧西林金黄色葡萄球菌的爆发。
{"title":"[Prevalence and genotypes of methicillin-resistant Staphylococcus aureus (MRSA) in humans, animals and foods in the Czech Republic].","authors":"Renáta Karpíšková, Kristýna Brodíková, Ivana Koláčková","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Methicillin-resistant Staphylococcus aureus (MRSA) strains are emerging zoonotic pathogens that are of importance not only to human but also to veterinary medicine. MRSA strains spread among humans and animals and can also be transmitted through foods. In this article, we provide a summary of the prevalence of MRSA in the Czech Republic, focusing on the One Health concept, which explores the relationships between human and animal health and the environment. This approach, together with collaboration between health professionals, veterinarians and public health experts, can provide valuable insights and help in preventing and controlling MRSA outbreaks.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"29 2","pages":"43-45"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142977766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Microbiological methods for identification of the etiological agents of bloodstream infections with focus on the T2Bacteria Panel]. [血流感染病原鉴定的微生物学方法,重点是T2Bacteria Panel]。
Q3 Medicine Pub Date : 2023-03-01
Lucie Cíchová, Milena Antušková, Olga Džupová

Blood culture is the gold standard method for identifying the etiological agents of bloodstream infections. A relatively low sensitivity and a long time to detection are its main disadvantages, resulting in delayed administration of pathogen-specific antibiotic therapy and the need to initiate empiric treatment with broad-spectrum antibiotics. Such an approach negatively affects overall treatment outcomes and contributes to the spread of antibiotic resistance. Research in recent years has allowed the introduction of methods for rapid identification of pathogenic microbes from positive blood cultures, as well as methods for direct detection of bacteria and fungi from whole blood without the need for prior culture. Direct detection tests from whole blood have dramatically reduced the time to identify the causative pathogen of a bloodstream infection, but they also have their limitations. Methods that combine PCR and T2-weighted magnetic resonance imaging appear promising. This article provides an overview of diagnostic tests and a detailed description of the T2Bacteria Panel, its advantages and disadvantages based on prospective observational studies and review articles. Future implementation of these methods in the diagnosis of bloodstream infections and potentially localized infections could have a positive impact on the early administration of pathogen-specific antimicrobial therapy and subsequently on overall treatment outcomes, as well as on reducing the spread of antibiotic resistance.

血培养是鉴别血流感染病原的金标准方法。相对较低的敏感性和较长的检测时间是其主要缺点,导致给予病原体特异性抗生素治疗延迟,需要开始使用广谱抗生素进行经验性治疗。这种方法对总体治疗结果产生负面影响,并有助于抗生素耐药性的传播。近年来的研究已经允许引入从阳性血液培养物中快速鉴定病原微生物的方法,以及不需要事先培养就可以从全血中直接检测细菌和真菌的方法。全血的直接检测测试大大缩短了识别血液感染的致病病原体的时间,但它们也有其局限性。结合PCR和t2加权磁共振成像的方法似乎很有前景。本文基于前瞻性观察性研究和综述性文章,概述了诊断测试,并详细描述了T2Bacteria小组及其优缺点。未来在血液感染和潜在局部感染诊断中实施这些方法,可能对早期给予病原体特异性抗菌药物治疗以及随后的总体治疗结果产生积极影响,并对减少抗生素耐药性的传播产生积极影响。
{"title":"[Microbiological methods for identification of the etiological agents of bloodstream infections with focus on the T2Bacteria Panel].","authors":"Lucie Cíchová,&nbsp;Milena Antušková,&nbsp;Olga Džupová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Blood culture is the gold standard method for identifying the etiological agents of bloodstream infections. A relatively low sensitivity and a long time to detection are its main disadvantages, resulting in delayed administration of pathogen-specific antibiotic therapy and the need to initiate empiric treatment with broad-spectrum antibiotics. Such an approach negatively affects overall treatment outcomes and contributes to the spread of antibiotic resistance. Research in recent years has allowed the introduction of methods for rapid identification of pathogenic microbes from positive blood cultures, as well as methods for direct detection of bacteria and fungi from whole blood without the need for prior culture. Direct detection tests from whole blood have dramatically reduced the time to identify the causative pathogen of a bloodstream infection, but they also have their limitations. Methods that combine PCR and T2-weighted magnetic resonance imaging appear promising. This article provides an overview of diagnostic tests and a detailed description of the T2Bacteria Panel, its advantages and disadvantages based on prospective observational studies and review articles. Future implementation of these methods in the diagnosis of bloodstream infections and potentially localized infections could have a positive impact on the early administration of pathogen-specific antimicrobial therapy and subsequently on overall treatment outcomes, as well as on reducing the spread of antibiotic resistance.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"29 1","pages":"20-25"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10017129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pseudomonas aeruginosa virulence factors as a therapeutic target in multidrug-resistant strains]. [铜绿假单胞菌毒力因子作为多重耐药菌株的治疗靶点]。
Q3 Medicine Pub Date : 2023-03-01
Kristýna Nováková, Milan Kolář

Pseudomonas aeruginosa (PSAE) is known for its ability to form biofilm and produce other virulence factors associated with a resistant phenotype. Multidrug-resistant (MDR) PSAE strains represent a serious problem in healthcare and are the focus of an increasing number of studies dealing with the therapy of infections caused by these bacteria. Nowadays, a number of studies focus on the presence of virulence factors rather than on the mechanisms of resistance to the antibiotics used, as it is the study of virulence factors that makes it possible to expand the possibilities of effective and efficient therapy. This review describes the virulence factors produced by the one of the five PSAE secretion systems that have the potential to become targets for so-called antivirulence therapy, have been described. These are mainly alkaline protease, elastase B, exotoxins A, S and Y and pyocyanin. In addition to specific virulence factors, recent studies have focused on the components of the PSAE secretion systems that mediate the transport of toxins and lytic enzymes out of the bacterial cell. Inhibition of specific molecules for type 2 and 3 secretion systems may prevent secretion of virulence factors into the extracellular space and host cells, which would have a significant impact on reducing PSAE virulence.

铜绿假单胞菌(PSAE)以其形成生物膜和产生与抗性表型相关的其他毒力因子的能力而闻名。多药耐药(MDR) PSAE菌株在医疗保健中是一个严重的问题,并且是越来越多的研究的焦点,这些研究涉及由这些细菌引起的感染的治疗。目前,许多研究侧重于毒力因子的存在,而不是对所使用抗生素的耐药机制,因为只有对毒力因子的研究才能扩大有效和高效治疗的可能性。这篇综述描述了由五种PSAE分泌系统之一产生的毒力因子,这些系统有可能成为所谓的抗毒治疗的目标。它们主要是碱性蛋白酶、弹性蛋白酶B、外毒素A、S、Y和花青素。除了特定的毒力因子外,最近的研究还集中在PSAE分泌系统的组成部分,该系统介导毒素和裂解酶的运输出细菌细胞。抑制2型和3型分泌系统的特定分子可以阻止毒力因子分泌到细胞外空间和宿主细胞中,这将对降低PSAE的毒力产生重要影响。
{"title":"[Pseudomonas aeruginosa virulence factors as a therapeutic target in multidrug-resistant strains].","authors":"Kristýna Nováková,&nbsp;Milan Kolář","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Pseudomonas aeruginosa (PSAE) is known for its ability to form biofilm and produce other virulence factors associated with a resistant phenotype. Multidrug-resistant (MDR) PSAE strains represent a serious problem in healthcare and are the focus of an increasing number of studies dealing with the therapy of infections caused by these bacteria. Nowadays, a number of studies focus on the presence of virulence factors rather than on the mechanisms of resistance to the antibiotics used, as it is the study of virulence factors that makes it possible to expand the possibilities of effective and efficient therapy. This review describes the virulence factors produced by the one of the five PSAE secretion systems that have the potential to become targets for so-called antivirulence therapy, have been described. These are mainly alkaline protease, elastase B, exotoxins A, S and Y and pyocyanin. In addition to specific virulence factors, recent studies have focused on the components of the PSAE secretion systems that mediate the transport of toxins and lytic enzymes out of the bacterial cell. Inhibition of specific molecules for type 2 and 3 secretion systems may prevent secretion of virulence factors into the extracellular space and host cells, which would have a significant impact on reducing PSAE virulence.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"29 1","pages":"11-19"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10017130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Resistance of bacterial pathogens isolated from the lower respiratory tract and their clonality in intensive care patients in a post-COVID-19 period]. [covid -19后重症监护患者下呼吸道分离病原菌的耐药性及其克隆性]。
Q3 Medicine Pub Date : 2023-03-01
Vendula Pudová, Kristýna Hrycová, Kateřina Fišerová, Miroslava Htoutou Sedláková, Lenka Doubravská, Milan Kolář

Objectives: The period of the COVID-19 pandemic had a significant impact on the healthcare system, including its effect on compliance with the established procedures of a rational antibiotic policy, especially in the context of nosocomial pneumonia, where it was very difficult to distinguish a possible bacterial superinfection from a severe inflammatory reaction caused by the SARS-CoV-2 virus. The aim of the present study was to analyze the antimicrobial resistance of bacterial pathogens isolated from the lower respiratory tract and their clonality in intensive care patients in 2022 and to compare it with the previous COVID-19 period.

Material and methods: Bacterial strains isolated from the lower respiratory tract (LRT) of patients hospitalized at the Department of Anaesthesiology, Resuscitation and Intensive Care, Olomouc University Hospital (DARIC) over a three-year period (January 1, 2020 - December 31, 2022) were included in the study. The susceptibility to antibiotics was determined by the standard microdilution method according to the EUCAST criteria, and selected isolates were compared using pulsed-field gel electrophoresis (PFGE).

Results: The resistance of the most common bacterial pathogens isolated from the LRT of patients hospitalized at DARIC did not change significantly during the COVID-19 (2020-2021) and post-COVID-19 (2022) periods, with the exception of Serratia marcescens and Enterococcus faecium species. These two showed an increase in the number of strains during the COVID-19 pandemic, as well as a significant increase in the proportion of resistant strains. In the case of Serratia marcescens, there was a subsequent decrease in the number of isolates and their resistance in 2022. For Enterococcus faecium, the total number of isolates also decreased significantly, but the frequency of vancomycin-resistant isolates (VRE) continued to increase. During the COVID-19 pandemic, increased VRE detection can be linked to proven clonal spread, but significant clonality was no longer confirmed in 2022. Comparison of similarity by PFGE in other bacterial species also did not reveal significant horizontal transmission between patients in the post-COVID-19 period, as most isolates (85%) showed a unique restriction profile.

Conclusions: The results indicate that the frequency and antimicrobial resistance of the majority of the most common bacterial pathogens from the LRT of patients hospitalized at DARIC in the post-pandemic period remain comparable to the time before and during the COVID-19 pandemic outbreak. An exception is Enterococcus faecium, which showed an increase in vancomycin resistance in both the COVID-19 and the post-COVID-19 periods.

目的:COVID-19大流行期间对医疗保健系统产生了重大影响,包括其对合理抗生素政策既定程序的依从性的影响,特别是在院内肺炎的情况下,很难区分可能的细菌重复感染与SARS-CoV-2病毒引起的严重炎症反应。本研究的目的是分析2022年重症监护患者下呼吸道分离的细菌病原菌的耐药性及其克隆性,并与之前的COVID-19时期进行比较。材料和方法:从奥洛穆茨大学医院(DARIC)麻醉、复苏和重症监护科(DARIC)住院患者的下呼吸道(LRT)中分离的细菌菌株被纳入研究,为期三年(2020年1月1日至2022年12月31日)。采用标准微量稀释法根据EUCAST标准测定菌株对抗生素的药敏,并采用脉冲场凝胶电泳(PFGE)对所选菌株进行比较。结果:在2019冠状病毒病(2020-2021)和2019冠状病毒病后(2022)期间,从DARIC住院患者LRT中分离出的最常见细菌病原体的耐药性没有显著变化,但粘质沙雷氏菌和屎肠球菌除外。这两项研究显示,在2019冠状病毒病大流行期间,菌株数量增加,耐药菌株比例显著增加。粘质沙雷氏菌的分离株数量随后在2022年有所下降,耐药性也有所下降。粪肠球菌(Enterococcus faecium)总分离株数也明显减少,但万古霉素耐药分离株(VRE)频次持续增加。在2019冠状病毒病大流行期间,VRE检测的增加可能与已证实的克隆传播有关,但在2022年不再确认明显的克隆性。其他细菌种类的PFGE相似性比较也未显示出covid -19后时期患者之间显著的水平传播,因为大多数分离株(85%)显示出独特的限制性基因图谱。结论:结果表明,大流行后期间DARIC住院患者LRT中大多数最常见的细菌病原体的频率和耐药性与COVID-19大流行爆发前和期间保持相当。一个例外是屎肠球菌,在COVID-19和COVID-19后时期,它对万古霉素的耐药性都有所增加。
{"title":"[Resistance of bacterial pathogens isolated from the lower respiratory tract and their clonality in intensive care patients in a post-COVID-19 period].","authors":"Vendula Pudová,&nbsp;Kristýna Hrycová,&nbsp;Kateřina Fišerová,&nbsp;Miroslava Htoutou Sedláková,&nbsp;Lenka Doubravská,&nbsp;Milan Kolář","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>The period of the COVID-19 pandemic had a significant impact on the healthcare system, including its effect on compliance with the established procedures of a rational antibiotic policy, especially in the context of nosocomial pneumonia, where it was very difficult to distinguish a possible bacterial superinfection from a severe inflammatory reaction caused by the SARS-CoV-2 virus. The aim of the present study was to analyze the antimicrobial resistance of bacterial pathogens isolated from the lower respiratory tract and their clonality in intensive care patients in 2022 and to compare it with the previous COVID-19 period.</p><p><strong>Material and methods: </strong>Bacterial strains isolated from the lower respiratory tract (LRT) of patients hospitalized at the Department of Anaesthesiology, Resuscitation and Intensive Care, Olomouc University Hospital (DARIC) over a three-year period (January 1, 2020 - December 31, 2022) were included in the study. The susceptibility to antibiotics was determined by the standard microdilution method according to the EUCAST criteria, and selected isolates were compared using pulsed-field gel electrophoresis (PFGE).</p><p><strong>Results: </strong>The resistance of the most common bacterial pathogens isolated from the LRT of patients hospitalized at DARIC did not change significantly during the COVID-19 (2020-2021) and post-COVID-19 (2022) periods, with the exception of Serratia marcescens and Enterococcus faecium species. These two showed an increase in the number of strains during the COVID-19 pandemic, as well as a significant increase in the proportion of resistant strains. In the case of Serratia marcescens, there was a subsequent decrease in the number of isolates and their resistance in 2022. For Enterococcus faecium, the total number of isolates also decreased significantly, but the frequency of vancomycin-resistant isolates (VRE) continued to increase. During the COVID-19 pandemic, increased VRE detection can be linked to proven clonal spread, but significant clonality was no longer confirmed in 2022. Comparison of similarity by PFGE in other bacterial species also did not reveal significant horizontal transmission between patients in the post-COVID-19 period, as most isolates (85%) showed a unique restriction profile.</p><p><strong>Conclusions: </strong>The results indicate that the frequency and antimicrobial resistance of the majority of the most common bacterial pathogens from the LRT of patients hospitalized at DARIC in the post-pandemic period remain comparable to the time before and during the COVID-19 pandemic outbreak. An exception is Enterococcus faecium, which showed an increase in vancomycin resistance in both the COVID-19 and the post-COVID-19 periods.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"29 1","pages":"4-10"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10017124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A case of botulism in the Czech Republic and current possibilities for detecting the neurotoxin produced by Clostridium botulinum]. [捷克共和国一例肉毒杆菌中毒和目前检测肉毒梭菌产生的神经毒素的可能性]。
Q3 Medicine Pub Date : 2023-03-01
Jiří Dresler, Kateřina Matúšková, Zuzana Kalaninová, Petr Pompach, Michael Volný, Petr Novák, Anna Burantová, Michal Holub

In the Czech Republic, botulism is a rare life-threatening disease. A total of 155 cases have been reported since 1960; according to the ISIN (formerly EPIDAT) database, there have been only three isolated cases since 2013, with the exception of a single occurrence of familial botulism in 2013. In our work, we present the occurrence of botulism after ingestion of pâté of untraceable origin by a couple who were hospitalized for botulotoxin food poisoning in July 2022. Their neurological symptoms were dominated by dysarthria. After administration of antibotulinum serum, their condition improved significantly. Patient samples were analyzed using affinity carriers and MALDI mass spectrometry, a modern highly sensitive technique for detecting the presence of botulinum neurotoxins. Unlike traditional detection by a difficult and costly biological experiment on mice, the above analysis does not require the killing of laboratory animals.

在捷克共和国,肉毒杆菌中毒是一种罕见的危及生命的疾病。自1960年以来共报告了155例;根据ISIN(以前的EPIDAT)数据库,自2013年以来,除了2013年发生的一例家族性肉毒杆菌中毒外,只有三例孤立病例。在我们的工作中,我们介绍了一对夫妇在2022年7月因肉毒毒素食物中毒住院后摄入来源不明的肉毒杆菌后发生肉毒中毒的情况。神经系统症状以构音障碍为主。给予抗肉毒杆菌血清后,病情明显好转。使用亲和载体和MALDI质谱分析患者样本,这是一种用于检测肉毒杆菌神经毒素存在的现代高灵敏度技术。与传统的通过困难和昂贵的小鼠生物实验进行检测不同,上述分析不需要杀死实验动物。
{"title":"[A case of botulism in the Czech Republic and current possibilities for detecting the neurotoxin produced by Clostridium botulinum].","authors":"Jiří Dresler,&nbsp;Kateřina Matúšková,&nbsp;Zuzana Kalaninová,&nbsp;Petr Pompach,&nbsp;Michael Volný,&nbsp;Petr Novák,&nbsp;Anna Burantová,&nbsp;Michal Holub","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In the Czech Republic, botulism is a rare life-threatening disease. A total of 155 cases have been reported since 1960; according to the ISIN (formerly EPIDAT) database, there have been only three isolated cases since 2013, with the exception of a single occurrence of familial botulism in 2013. In our work, we present the occurrence of botulism after ingestion of pâté of untraceable origin by a couple who were hospitalized for botulotoxin food poisoning in July 2022. Their neurological symptoms were dominated by dysarthria. After administration of antibotulinum serum, their condition improved significantly. Patient samples were analyzed using affinity carriers and MALDI mass spectrometry, a modern highly sensitive technique for detecting the presence of botulinum neurotoxins. Unlike traditional detection by a difficult and costly biological experiment on mice, the above analysis does not require the killing of laboratory animals.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"29 1","pages":"26-28"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10017128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Application of second- and third-generation sequencing for bacterial typing]. 【第二代和第三代测序在细菌分型中的应用】。
Q3 Medicine Pub Date : 2022-12-01
Matěj Bedíček, Kristýna Dufková, Markéta Nykrýnová, Jana Hansliková, Martina Lengerová

Whole-genome sequencing (WGS) is a modern method that allows deep understanding of studied organisms and is currently gaining importance in molecular microbiology. Data obtained by whole-genome sequencing can be used for a number of different analyses, specifically in bacterial epidemiology. The authors provide an overview of the methods that are used for bacterial typing, description of their principles with subsequent possibilities for evaluation of the obtained data and applications in hospital research.

全基因组测序(WGS)是一种现代方法,可以深入了解所研究的生物体,目前在分子微生物学中越来越重要。全基因组测序获得的数据可用于许多不同的分析,特别是细菌流行病学。作者概述了用于细菌分型的方法,描述了其原理,以及随后对获得的数据和在医院研究中的应用进行评估的可能性。
{"title":"[Application of second- and third-generation sequencing for bacterial typing].","authors":"Matěj Bedíček,&nbsp;Kristýna Dufková,&nbsp;Markéta Nykrýnová,&nbsp;Jana Hansliková,&nbsp;Martina Lengerová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Whole-genome sequencing (WGS) is a modern method that allows deep understanding of studied organisms and is currently gaining importance in molecular microbiology. Data obtained by whole-genome sequencing can be used for a number of different analyses, specifically in bacterial epidemiology. The authors provide an overview of the methods that are used for bacterial typing, description of their principles with subsequent possibilities for evaluation of the obtained data and applications in hospital research.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"28 4","pages":"106-115"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10022078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Respiratory manifestations of post-COVID syndrome]. [新冠肺炎后综合征的呼吸道表现]。
Q3 Medicine Pub Date : 2022-12-01
J Mizera, Petr Jakubec, Milan Sova, Martin Vykopal, Pavol Pobeha, Samuel Genzor

Overcoming infection with coronavirus disease 2019 (COVID-19) can lead to the persistence of various symptoms in some patients. The complex of symptoms causally related to severe acute respiratory coronavirus 2 infection is called post-COVID syndrome. One of the most common respiratory complications is pulmonary fibrosis, especially after critical course of the disease. In some patients, however, only the peripheral airways are affected by the air-trapping seen on high-resolution computed tomography scans. Less common respiratory complications include sarcoidosis and pneumatoceles. This narrative review summarizes current knowledge about pulmonary involvement as part of post-COVID syndrome.

克服2019冠状病毒病(COVID-19)感染可能会导致一些患者持续出现各种症状。与严重急性呼吸道冠状病毒感染有因果关系的症状综合体被称为“后冠状病毒综合征”。最常见的呼吸系统并发症之一是肺纤维化,特别是在疾病的关键病程之后。然而,在一些患者中,只有周围气道受到高分辨率计算机断层扫描所见的空气捕获的影响。较不常见的呼吸道并发症包括结节病和气肿。这篇叙述性综述总结了目前关于肺部受累作为covid后综合征的一部分的知识。
{"title":"[Respiratory manifestations of post-COVID syndrome].","authors":"J Mizera,&nbsp;Petr Jakubec,&nbsp;Milan Sova,&nbsp;Martin Vykopal,&nbsp;Pavol Pobeha,&nbsp;Samuel Genzor","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Overcoming infection with coronavirus disease 2019 (COVID-19) can lead to the persistence of various symptoms in some patients. The complex of symptoms causally related to severe acute respiratory coronavirus 2 infection is called post-COVID syndrome. One of the most common respiratory complications is pulmonary fibrosis, especially after critical course of the disease. In some patients, however, only the peripheral airways are affected by the air-trapping seen on high-resolution computed tomography scans. Less common respiratory complications include sarcoidosis and pneumatoceles. This narrative review summarizes current knowledge about pulmonary involvement as part of post-COVID syndrome.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"28 4","pages":"116-128"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10017127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Role of chloramphenicol in current clinical practice]. [氯霉素在当前临床中的作用]。
Q3 Medicine Pub Date : 2022-12-01
Olga Džupová, Jiří Beneš

Introduction: Chloramphenicol is an antibiotic with a broad spectrum of action and excellent tissue penetration. It had been widely used in clinical practice until the 1970s, but due to its potential myelotoxicity, it was gradually replaced by newly introduced antibiotics in the following years. The aim of the study was to find out to what extent and with what experience it is currently used in the Czech Republic.

Methods: A questionnaire survey was conducted in July and August 2022. The heads of all inpatient infectious diseases departments, hospital infectious diseases specialists and consulting microbiologists from antibiotic centers in large teaching hospitals without an infectious diseases department were asked to fill out the questionnaire.

Results: Thirty-five out of 39 hospitals contacted took part in the study, a response rate of 90 %. Chloramphenicol is used in 37 % of participating hospitals, with a frequency of up to 10 patients treated per year. The most common indications are brain abscesses, purulent meningitis, intra-abdominal, pelvic and lung abscesses, and polymicrobial infections with anaerobes. Chloramphenicol is almost always administered as an alternative antibiotic because of polyvalent allergy, bacterial resistance, and failure of previous treatment. Sixty-six percent of respondents described the effect as reliable or partially reliable, 34 % did not rate the effect. Fifty-two percent of respondents considered a dose of 8-9 g to be the maximum dose for an adult patient. In practice, 60 % of respondents did not encounter or could not assess the myelotoxic effects of chloramphenicol, 37 % observed reversible bone marrow suppression at least once, and only one respondent encountered aplastic anemia once.

Conclusion: Unfortunately, chloramphenicol is currently used in less than half of hospitals in the Czech Republic. Because of its unique properties, it still has a place in today's anti-infective treatment. When properly indicated and after weighing the benefits and risks, it can be a suitable and sometimes life-saving alternative.

氯霉素是一种具有广谱作用和良好的组织穿透性的抗生素。直到20世纪70年代,它在临床实践中被广泛使用,但由于其潜在的髓毒性,在接下来的几年里,它逐渐被新引入的抗生素所取代。这项研究的目的是找出目前在捷克共和国使用的程度和经验。方法:于2022年7 - 8月进行问卷调查。调查对象为无传染病科的大型教学医院的所有住院传染病科主任、医院传染病专家和抗生素中心的咨询微生物学家。结果:在联系的39家医院中,有35家参与了研究,回复率为90%。37%的参与医院使用氯霉素,每年最多治疗10名患者。最常见的适应症是脑脓肿,化脓性脑膜炎,腹腔,盆腔和肺脓肿,以及厌氧菌的多微生物感染。由于多价过敏、细菌耐药和既往治疗失败,氯霉素几乎总是作为替代抗生素使用。66%的受访者认为效果可靠或部分可靠,34%的受访者认为效果不可靠。52%的答复者认为8- 9g的剂量是成年患者的最大剂量。实际上,60%的受访者没有遇到或无法评估氯霉素的骨髓毒性作用,37%观察到可逆的骨髓抑制至少一次,只有一名受访者遇到再生障碍性贫血一次。结论:不幸的是,目前在捷克共和国不到一半的医院使用氯霉素。由于其独特的性质,它在今天的抗感染治疗中仍然占有一席之地。在适当指出并权衡利弊后,它可能是一种合适的,有时甚至可以挽救生命的替代方案。
{"title":"[Role of chloramphenicol in current clinical practice].","authors":"Olga Džupová,&nbsp;Jiří Beneš","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Chloramphenicol is an antibiotic with a broad spectrum of action and excellent tissue penetration. It had been widely used in clinical practice until the 1970s, but due to its potential myelotoxicity, it was gradually replaced by newly introduced antibiotics in the following years. The aim of the study was to find out to what extent and with what experience it is currently used in the Czech Republic.</p><p><strong>Methods: </strong>A questionnaire survey was conducted in July and August 2022. The heads of all inpatient infectious diseases departments, hospital infectious diseases specialists and consulting microbiologists from antibiotic centers in large teaching hospitals without an infectious diseases department were asked to fill out the questionnaire.</p><p><strong>Results: </strong>Thirty-five out of 39 hospitals contacted took part in the study, a response rate of 90 %. Chloramphenicol is used in 37 % of participating hospitals, with a frequency of up to 10 patients treated per year. The most common indications are brain abscesses, purulent meningitis, intra-abdominal, pelvic and lung abscesses, and polymicrobial infections with anaerobes. Chloramphenicol is almost always administered as an alternative antibiotic because of polyvalent allergy, bacterial resistance, and failure of previous treatment. Sixty-six percent of respondents described the effect as reliable or partially reliable, 34 % did not rate the effect. Fifty-two percent of respondents considered a dose of 8-9 g to be the maximum dose for an adult patient. In practice, 60 % of respondents did not encounter or could not assess the myelotoxic effects of chloramphenicol, 37 % observed reversible bone marrow suppression at least once, and only one respondent encountered aplastic anemia once.</p><p><strong>Conclusion: </strong>Unfortunately, chloramphenicol is currently used in less than half of hospitals in the Czech Republic. Because of its unique properties, it still has a place in today's anti-infective treatment. When properly indicated and after weighing the benefits and risks, it can be a suitable and sometimes life-saving alternative.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"28 4","pages":"101-105"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10022080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Klinicka mikrobiologie a infekcni lekarstvi
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1